Distinguishing multiple primary lung cancers from intrapulmonary metastasis using CT-based radiomics

被引:3
|
作者
Huang, Mei [1 ]
Xu, Qinmei [1 ,3 ]
Zhou, Mu [2 ]
Li, Xinyu [1 ,4 ]
Lv, Wenhui [1 ]
Zhou, Changsheng [1 ]
Wu, Ren [1 ,4 ]
Zhou, Zhen [5 ]
Chen, Xingzhi [5 ]
Huang, Chencui [5 ]
Lu, Guangming [1 ,6 ]
机构
[1] Nanjing Univ, Med Sch, Affiliated Jinling Hosp, Dept Med Imaging, Nanjing, Peoples R China
[2] Rutgers State Univ, Dept Comp Sci, 110 Frelinghuysen Rd, Piscataway, NJ 08854 USA
[3] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA USA
[4] Nanjing Med Univ, Jinling Hosp, Sch Med Imaging, Dept Med Imaging, Nanjing, Peoples R China
[5] Deepwise Inc, Deepwise AI Lab, Beijing, Peoples R China
[6] Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Imaging, 305 Eastern Zhongshan Rd, Nanjing 210002, Peoples R China
关键词
Multiple primary lung cancers; Intrapulmonary metastasis; Radiomics; Refined-radiomics; FORTHCOMING 8TH EDITION; CLASSIFICATION; TUMORS; DIFFERENTIATE;
D O I
10.1016/j.ejrad.2022.110671
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To develop CT-based radiomics models that can efficiently distinguish between multiple primary lung cancers (MPLCs) and intrapulmonary metastasis (IPMs).Method: This retrospective study included 127 patients with 254 lung tumors pathologically proved as MPLCs or IPMs between May 2009 and January 2020. Radiomics features of lung tumors were extracted from baseline CT scans. Particularly, we incorporated tumor-focused, refined radiomics by calculating relative radiomics differ-ences from paired tumors of individual patients. We applied the L1-norm regularization and analysis of variance to select informative radiomics features for constructing radiomics model (RM) and refined radiomics model (RRM). The performance was assessed by the area under the receiver operating characteristic curve (AUC-ROC). The two radiomics models were compared with the clinical-CT model (CCM, including clinical and CT semantic features). We incorporated both radiomics features to construct fusion model1 (FM1). We also, build fusion model2 (FM2) by combing both radiomics, clinical and CT semantic features. The performance of the FM1 and FM2 were further compared with that of the RRM.Results: On the validation set, the RM achieved an AUC of 0.857. The RRM demonstrated improved performance (validation set AUC, 0.870) than the RM, and showed significant differences compared with the CCM (validation set AUC, 0.782). Fusion models further led prediction performance (validation set AUC, FM1:0.885; FM2:0.889). There were no significant differences among the performance of the FM1, the FM2 and the RRM.Conclusions: The CT-based radiomics models presented good performance on the discrimination between MPLCs and IPMs, demonstrating the potential for early diagnosis and treatment guidance for MPLCs and IPMs.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Pathology-Imaging Agreement in Distinguishing Separate Primary Tumours and Intrapulmonary Metastasis in Staging of Multiple Lung Cancers
    Viola, Patrizia
    Devaraj, Anand
    Lim, Eric
    Luciano, Giulia
    Popat, Sanjay
    Nicholson, Andrew G.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S261 - S262
  • [2] A pairwise radiomics algorithm-lesion pair relation estimation model for distinguishing multiple primary lung cancer from intrapulmonary metastasis
    Chen, Ting-Fei
    Yang, Lei
    Chen, Hai-Bin
    Zhou, Zhi-Guo
    Wu, Zhen-Tian
    Luo, Hong-He
    Li, Qiong
    Zhu, Ying
    PRECISION CLINICAL MEDICINE, 2023, 6 (04)
  • [3] DISTINGUISH SYNCHRONOUS MULTIPLE PRIMARY LUNG CANCERS FROM INTRAPULMONARY METASTASIS BY GENOME SEQUENCING
    Liu, Yu
    Li, Lin
    Yin, Guangliang
    Lin, Dongmei
    Liu, Xiangyang
    Gao, Yanning
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S146 - S147
  • [4] Synchronous Multiple Lung Cancers with Lymph Node Metastasis and Different EGFR Mutations: Intrapulmonary Metastasis or Multiple Primary Lung Cancers?
    Qu, Rirong
    Tu, Dehao
    Ping, Wei
    Zhang, Ni
    Fu, Xiangning
    ONCOTARGETS AND THERAPY, 2021, 14 : 1093 - 1099
  • [5] Challenges in diagnosis of multiple lung cancers: synchronous double primary lung or intrapulmonary metastasis?
    El Hadhri, I.
    Ayadi, R.
    Braham, E.
    Yaiche, R.
    Bouassida, I.
    Mallek, I.
    Ismail, O.
    Ben Slama, S.
    Ayadi, A.
    VIRCHOWS ARCHIV, 2024, 485 : S439 - S439
  • [6] Discrimination of Multiple Primary Lung Cancers From Intrapulmonary Metastasis Based on the Expression of Four Cancer-related Proteins
    Ono, Kenji
    Sugio, Kenji
    Uramoto, Hidetaka
    Baba, Tetsuro
    Ichiki, Yoshinobu
    Takenoyama, Mitsuhiro
    Hanagiri, Takeshi
    Oyama, Tsunehiro
    Yasumoto, Kosei
    CANCER, 2009, 115 (15) : 3489 - 3500
  • [7] A Novel Algorithm to Differentiate Between Multiple Primary Lung Cancers and Intrapulmonary Metastasis in Multiple Lung Cancers With Multiple Pulmonary Sites of Involvement
    Suh, Young Joo
    Lee, Hyun-Ju
    Sung, Pamela
    Yoen, Heera
    Kim, Sewoo
    Han, Seungchul
    Park, Sungeun
    Hong, Jung Hee
    Kim, Heekyung
    Lim, Jiyeon
    Kim, Hyungjin
    Yoon, Soon Ho
    Jeon, Yoon Kyung
    Kim, Young Tae
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (02) : 203 - 215
  • [8] Multiple lung carcinoma: Primary or intrapulmonary metastasis?
    Ravella, Lucie
    Barritault, Marc
    Bringuier, Pierre-Paul
    Chalabreysse, Lara
    Thivolet-Bejui, Francoise
    Maury, Jean-Michel
    Duruisseaux, Michael
    Brevet, Marie
    ANNALES DE PATHOLOGIE, 2018, 38 (03) : 202 - 205
  • [9] CT-Based Radiomics for the Preoperative Prediction of Occult Peritoneal Metastasis in Epithelial Ovarian Cancers
    Li, Jiaojiao
    Zhang, Jianing
    Wang, Fang
    Ma, Juanwei
    Cui, Shujun
    Ye, Zhaoxiang
    ACADEMIC RADIOLOGY, 2024, 31 (05) : 1918 - 1930
  • [10] Genetic mutations-based criteria to distinguish multiple primary lung cancers from intrapulmonary metastasis in patients with lung tumors.
    Li, Zhenhua
    Lv, Huilai
    Zhang, Fan
    Zhu, Ziming
    Guo, Qiang
    Wang, Mingbo
    Huang, Chao
    Guo, Lijie
    Meng, Fanfei
    Yuan, Shaohua
    Shi, Xiaoliang
    Tian, Ziqiang
    Pang, Fei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)